Alternatives to amyloid for Alzheimer's disease therapies—a symposium report
For decades, Alzheimer's disease research has focused on amyloid as the primary pathogenic agent. This focus has driven the development of numerous amyloid-targeting therapies; however, with one possible exception, none of these therapies have been effective in preventing or delaying cognitive...
Main Authors: | , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Wiley
2021
|
Online Access: | https://hdl.handle.net/1721.1/129349 |